European UPC IP Litigation
2,007 annotated decisions
Page 23 of 84 · 2,007 total
QIAGEN Sciences, LLC v.bioMérieux S.A. and bioMérieux Deutschland GmbH
This is a procedural order from the Düsseldorf Local Division concerning European patent EP 2 726 883, in which the Claimant QIAGEN Sciences, LLC sought an extension of time to file its Reply to the Statement of defence and Defence to the Counterclaim for revocation. The Defendants had filed a confidentiality application alongside their defence, delaying the Claimant's access to unredacted documents. The court granted the extension, with the Defendants' consent, extending the deadlines to 15 September 2025.
Visibly Inc. v.Easee B.V. and Others
Visibly Inc. appealed an order of the Hamburg Local Division concerning security for legal costs in its patent infringement action against Easee. After the proceedings were stayed due to insolvency proceedings against the Easee companies, Visibly applied to withdraw the appeal citing an out-of-court settlement, to which Easee consented. The Court of Appeal permitted the withdrawal, declared the proceedings closed, and ordered reimbursement of 60% of the appeal court fees to Visibly.
FUJIFILM Corporation v.Kodak GmbH, Kodak Graphic Communications GmbH, and Kodak Holding GmbH
This enforcement proceeding arose from a decision of 2 April 2025 in UPC_CFI_365/2023 concerning European patent EP 3 511 174, in which FUJIFILM sought to enforce operative parts requiring the Kodak defendants to provide information, destroy infringing embodiments, recall products, and remove them from channels of commerce. The Mannheim Local Division found that the defendants had failed to comply with these obligations despite proper notification and service, rejecting the defendants' arguments regarding lack of warning and insufficient translations. The court imposed a three-pronged penalty regime including a lump-sum payment of €100,000, daily penalties of €2,500 until 4 August 2025, and escalated penalties of €10,000 per day thereafter.
EOFLOW Co., Ltd. v.Insulet Corporation
This case before the Milan Central Division of the Unified Patent Court concerned a revocation action filed by EOFLOW against Insulet's European patent EP4201327 (relating to a fluid delivery device for insulin pumps), along with Insulet's counterclaim for infringement against EOFLOW's EOPatch/GlucoMen Day Pump. The court addressed issues including the requirements for issuing a decision by default, the interpretation of patent claim language, and the application of cost caps under Article 1(3) of the Administrative Committee's decision. The court ultimately found infringement of claim 1 of EP4201327, issued injunctive relief, ordered information provision, product recall, and damages, with EOFLOW bearing the costs.
Nanoval GmbH & Co. KG v.ALD Vacuum Technologies GmbH (UPC_CFI_63/2025)
This case concerns an application by ALD Vacuum Technologies GmbH to revoke an evidence preservation and inspection order under Rule 198.1 EPGVerfO. The Local Chamber Munich of the Unified Patent Court rejected the application, holding that Nanoval GmbH had timely initiated main proceedings based on the revised deadline start date set by the rapporteur's order of March 18, 2025, which adjusted the deadline start to the date the expert's report was made accessible to Nanoval.
TIRU v.VALINEA ENERGIE
This is a procedural order from the Paris Local Division of the Unified Patent Court concerning EP 3 178 578 (a waste incineration installation patent held by TIRU). TIRU sought joinder of its parallel infringement actions against VALINEA ENERGIE and MAGUIN, transfer of the defendants' counterclaims for revocation to the Central Division Paris (already seized by VEOLIA PROPRETE's revocation action), and a stay of the infringement proceedings. The panel ordered the joinder of the two infringement actions, transferred the counterclaims for revocation to the Central Division, but rejected the request for a stay of the infringement proceedings at this stage.
Insulet Corporation v.EOFLOW Co., Ltd.
This case before the Milan Central Division of the Unified Patent Court concerned European patent EP4201327 (relating to fluid delivery devices for insulin pumps). EOFLOW sought revocation of the patent, while Insulet filed a counterclaim for infringement based on EOFLOW's EOPatch insulin pump. The Court issued a decision by default against EOFLOW on the revocation action, upheld the patent, found infringement by EOFLOW, and ordered injunctive relief, information disclosure, product recall, and damages with penalty payments for non-compliance.
Koninklijke Philips N.V. v.Belkin Limited, Belkin GmbH, Belkin International, Inc.
The Court of Appeal of the Unified Patent Court addressed Philips's application for cost assessment (R. 151 RoP) following a May 30, 2025 cost allocation order (65% to Belkin, 35% to Philips). Philips withdrew the application on the same day it was filed, explaining it was filed by mistake at the Court of Appeal instead of the Local Chamber Munich. The Court allowed the withdrawal, declared the proceedings terminated, and ordered no separate cost decision.
TIRU v.MAGUIN SAS
This is a procedural order from the Unified Patent Court's Local Division Paris concerning patent EP 3 178 578 (a waste incineration installation patent held by TIRU). TIRU had filed infringement actions against MAGUIN SAS (manufacturer of the alleged infringing incinerator) and VALINEA ENERGIE (exploiter of the incinerator), while VEOLIA PROPRETE had filed a revocation action before the Central Division Paris. The court ordered the joinder of the two infringement actions, transferred the counterclaims for revocation to the Central Division, and rejected TIRU's request for a stay of the infringement proceedings.
Edwards Lifesciences Corporation v.Meril Lifesciences PVT Limited, Meril GmbH, SMIS International OÜ, and Sormedica UAB
Edwards Lifesciences Corporation filed an infringement action against Meril entities and related companies concerning European Patent EP 2 628 464 B1, which relates to the transcatheter heart valve prosthesis Myval™ THV. The defendants filed counterclaims for revocation, and the proceedings were stayed pending the Technical Boards of Appeal decision, which upheld the patent in amended form (EP 464 B2). The parties subsequently reached a settlement agreement, which the Court confirmed by decision, ordering partial reimbursement of court fees to both sides and keeping certain terms of the agreement confidential.
Malikie Innovations Ltd. v.Discord Inc. and Discord Netherlands B.V.
An order from the Mannheim Local Division concerning EP 3 716 655, addressing a precautionary request by the claimant to harmonize time periods in an infringement action. The court rejected the request, holding that the counterclaim for revocation was only effectively served on the claimant on 10 July 2025, and therefore the time period for filing a defence to the counterclaim for revocation did not commence before that date.
Sun Patent Trust v.Vivo Mobile Communication Iberia SL, Vivo Tech GmbH, Vivo Mobile Communication Co., Ltd.
This procedural order from the Paris Local Division concerns the protection of confidential information in an infringement action brought by Sun Patent Trust against three Vivo entities regarding European Patent EP3852468. Sun Patent Trust filed applications under Rules 262.2 and 262A RoP to classify certain parts of its Statement of Claim and supporting Exhibits as confidential or highly confidential. The court granted the application in part, classifying specific information as confidential (accessible to Defendants' representatives, legal team, and named employees who signed NDAs) and highly confidential (restricted to the Defendants' representative, his legal team, and three named VIVO employees).
Sun Patent Trust v.Vivo Mobile Communication Iberia SL, Vivo Tech GmbH, and Vivo Mobile Communication Co., Ltd.
Sun Patent Trust filed an infringement action against three Vivo entities concerning European Patent EP3407524 before the Paris Local Division. Concurrently, Sun Patent Trust sought to classify certain information in its Statement of Claim and supporting Exhibits as confidential and highly confidential under Article 58 UPCA and Rule 262A RoP. The court issued a procedural order defining the scope of confidentiality protection, restricting access to confidential and highly confidential information to specific named representatives, legal teams, and limited employees of the Vivo defendants.
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Limited, VAB-Logistik UAB, SMIS International OÜ, Meril GmbH, Sormedica UAB, Interlux UAB
Edwards Lifesciences Corporation brought an infringement action against Meril Life Sciences and related entities concerning European Patent 3 769 722, which relates to a low profile delivery system for transcatheter heart valves. The defendants denied infringement and filed counterclaims for revocation, along with conditional applications to amend the patent. The Court of First Instance of the Unified Patent Court (Nordic-Baltic Regional Division) found the patent valid as amended, held that the defendants infringed claim 1, and ordered injunctive relief, corrective measures, provisional damages of EUR 500,000, and cost awards in favor of Edwards.
Lenovo (Singapore) Pte. Ltd. v.ASUSTek Computer Inc., ASUS Computer GmbH, and ASUSTEK (UK) LIMITED
Procedural order issued by the Local Chamber Munich concerning a FRAND interim hearing in patent infringement proceedings involving European Patent No. 3 682 587. The court set out a timetable for further pleadings on the FRAND objection, with ASUS permitted to file until August 11, 2025, and Lenovo to respond until September 1, 2025. The order also confirmed upcoming dates for a further interim hearing (September 25, 2025, by video conference) and the main oral hearing (November 19, 2025, in person in Munich).
Sibio Technology Limited v.Abbott Diabetes Care Inc.
Sibio Technology Limited filed a revocation action against Abbott Diabetes Care Inc. seeking to revoke European patent EP 3 831 283 B1, which relates to in vivo analyte monitoring devices. Sibio challenged the patent's validity on grounds of added subject matter, lack of novelty, and lack of inventive step. The Court of First Instance of the Unified Patent Court (Central Division, Paris Seat) dismissed the revocation action, finding that the alleged grounds for invalidity were either inadmissible as late-filed or not proven, and ordered the patent to be maintained as granted with costs borne by Sibio.
FUJIFILM Corporation v.Kodak GmbH, Kodak Graphic Communications GmbH, and Kodak Holding GmbH
FUJIFILM Corporation sued three Kodak entities before the Unified Patent Court Local Division Mannheim for infringement of EP 3 511 174 B1, a European patent relating to lithographic printing plate precursors. The proceedings concerning the UK part of the patent were separated following the ECJ's decision in BSH Hausgeräte (C-339/22). The court held that while it has jurisdiction to decide infringement of the UK part of a European bundle patent, it cannot revoke the UK part with erga omnes effect, and the defendants may raise invalidity as a defense with inter partes effect only.
bioMérieux UK Limited, bioMérieux SA, bioMérieux Deutschland GmbH, bioMérieux Italia S.p.A., bioMérieux Austria GmbH, bioMérieux Portugal Lda., bioMérieux Benelux BV v.Labrador Diagnostics LLC
This is a procedural order issued by the Court of First Instance of the Unified Patent Court (Central Division Milan) on 18 July 2025, following an interim conference in two related revocation proceedings concerning European Patent EP 3 756 767 B1 owned by Labrador Diagnostics LLC. The order addresses procedural matters including the narrowing of invalidity attacks, structuring of the oral hearing, and setting deadlines for further submissions by the parties.
FUJIFILM Corporation v.Kodak GmbH, Kodak Graphic Communications GmbH, and Kodak Holding GmbH
FUJIFILM Corporation sued three Kodak entities for alleged infringement of European patent EP 3 476 616, which relates to lithographic printing plate precursors, in Germany and the United Kingdom. The Mannheim Local Division separated the proceedings regarding the UK part of the patent following the ECJ's decision in BSH Hausgeräte (C-339/22). The court assessed the validity of the UK part as a mere prerequisite for infringement with inter partes effect, found the patent invalid, and dismissed the infringement action with costs borne by FUJIFILM.
bioMérieux UK Limited and bioMérieux SA et al. v.Labrador Diagnostics LLC
Procedural order issued by the Court of First Instance of the Unified Patent Court (Central Division Milan) in revocation proceedings concerning European Patent EP 3 756 767 B1 owned by Labrador Diagnostics LLC. Following an interim conference, the court directed bioMérieux to narrow down its approximately 50 invalidity attacks and 16 prior art citations to a manageable number, particularly focusing on Auxiliary Requests 1, 2, and 3, and ordered both parties to provide specific submissions and cost estimates by set deadlines.
Sanofi SA and Others v.Reddy Pharma SAS, betapharm Arzneimittel GmbH, and Dr Reddy's Srl
This is a procedural order from the Local Division Munich of the Unified Patent Court concerning infringement actions related to European patent n° 2 493 466. The order, issued following an interim conference on 17 July 2025, addresses procedural matters including the timeline for the oral hearing, expert testimony on obviousness, and confidentiality issues regarding interim damages calculations. The court confirmed the oral hearing dates of 14–17 October 2025 and the final interim conference for 12 September 2025.
Sanofi SA and related Sanofi entities v.Accord Healthcare entities and related defendants
This is a procedural order issued by the Local Division Munich of the Unified Patent Court on 17 July 2025, following an interim conference in consolidated infringement actions concerning European patent n° 2 493 466. The order addresses procedural matters including the pending written reasoned decision from the EPO Board of Appeal (which upheld the patent as granted at an oral hearing on 2-4 June 2025), the scheduling of the oral hearing for 14-17 October 2025, expert testimony on obviousness issues related to the Phase III TROPIC study, and confidentiality arrangements regarding interim damages calculations. The claimants are various Sanofi entities, and the defendants comprise four groups: Accord Healthcare entities, STADA entities, Reddy Pharma/betapharm/Dr Reddy's entities, and Zentiva entities.
Faro Technologies, Inc. v.PMT Technologies (Suzhou) Co., Ltd. and Blankenhorn GmbH
The Local Chamber Mannheim of the Unified Patent Court denied a request by Respondent PMT Technologies (Suzhou) Co., Ltd. to postpone the oral hearing scheduled for September 1, 2025 in proceedings concerning European Patent EP 4 001 835. The court held that the urgency inherent in interim measure proceedings requires very special circumstances for postponement, and that vacation absences of legal and patent attorney representatives do not constitute such circumstances. The court also offered the parties the opportunity to raise objections to Respondent 1 participating in the hearing via video link by July 24, 2025.
FUJIFILM Corporation v.Kodak GmbH, Kodak Graphic Communications GmbH, Kodak Holding GmbH
This order from the Mannheim Local Division concerns enforcement proceedings following a main decision of 2 April 2025 finding infringement of EP 3 511 174. The defendants (Kodak entities) sought confidentiality protection under Rule 262A RoP for information they were required to disclose during enforcement. The court rejected the request, holding that the defendants should have raised confidentiality in the main proceedings, that the main decision already restricted use of the information to the stated purposes, and that no specific risk of misuse was demonstrated.